These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39016173)

  • 21. HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent Mechanisms.
    Reszka-Blanco NJ; Sivaraman V; Zhang L; Su L
    J Virol; 2015 Aug; 89(15):7604-11. PubMed ID: 25972534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-Nef Protein Transfer to Endothelial Cells Requires Rac1 Activation and Leads to Endothelial Dysfunction Implications for Statin Treatment in HIV Patients.
    Chelvanambi S; Gupta SK; Chen X; Ellis BW; Maier BF; Colbert TM; Kuriakose J; Zorlutuna P; Jolicoeur P; Obukhov AG; Clauss M
    Circ Res; 2019 Oct; 125(9):805-820. PubMed ID: 31451038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How HIV Nef Proteins Hijack Membrane Traffic To Promote Infection.
    Buffalo CZ; Iwamoto Y; Hurley JH; Ren X
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unbiased proteomic profiling of host cell extracellular vesicle composition and dynamics upon HIV-1 infection.
    Martin-Jaular L; Nevo N; Schessner JP; Tkach M; Jouve M; Dingli F; Loew D; Witwer KW; Ostrowski M; Borner GHH; Théry C
    EMBO J; 2021 Apr; 40(8):e105492. PubMed ID: 33709510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I.
    Lin S; Nadeau PE; Wang X; Mergia A
    Retrovirology; 2012 Oct; 9():85. PubMed ID: 23067370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 27. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.
    Mujawar Z; Rose H; Morrow MP; Pushkarsky T; Dubrovsky L; Mukhamedova N; Fu Y; Dart A; Orenstein JM; Bobryshev YV; Bukrinsky M; Sviridov D
    PLoS Biol; 2006 Oct; 4(11):e365. PubMed ID: 17076584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells.
    Schaefer MR; Wonderlich ER; Roeth JF; Leonard JA; Collins KL
    PLoS Pathog; 2008 Aug; 4(8):e1000131. PubMed ID: 18725938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.
    Mujawar Z; Tamehiro N; Grant A; Sviridov D; Bukrinsky M; Fitzgerald ML
    Biochemistry; 2010 Sep; 49(38):8338-49. PubMed ID: 20731376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo.
    Welch JL; Kaddour H; Winchester L; Fletcher CV; Stapleton JT; Okeoma CM
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):90-98. PubMed ID: 31809364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells.
    Dubrovsky L; Brichacek B; Prashant NM; Pushkarsky T; Mukhamedova N; Fleetwood AJ; Xu Y; Dragoljevic D; Fitzgerald M; Horvath A; Murphy AJ; Sviridov D; Bukrinsky MI
    Cell Rep; 2022 Nov; 41(8):111674. PubMed ID: 36417867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-Nef and ADAM17-Containing Plasma Extracellular Vesicles Induce and Correlate with Immune Pathogenesis in Chronic HIV Infection.
    Lee JH; Schierer S; Blume K; Dindorf J; Wittki S; Xiang W; Ostalecki C; Koliha N; Wild S; Schuler G; Fackler OT; Saksela K; Harrer T; Baur AS
    EBioMedicine; 2016 Apr; 6():103-113. PubMed ID: 27211553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor Tim-3 in infected CD4
    Jacob RA; Edgar CR; Prévost J; Trothen SM; Lurie A; Mumby MJ; Galbraith A; Kirchhoff F; Haeryfar SMM; Finzi A; Dikeakos JD
    J Biol Chem; 2021 Sep; 297(3):101042. PubMed ID: 34358561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human immunodeficiency virus (HIV) Rev-binding protein (HRB) is a co-factor for HIV-1 Nef-mediated CD4 downregulation.
    Landi A; Timermans CG; Naessens E; Vanderstraeten H; Stove V; Verhasselt B
    J Gen Virol; 2016 Mar; 97(3):778-785. PubMed ID: 26701340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of HIV-1 Env on SERINC5 Antagonism.
    Beitari S; Ding S; Pan Q; Finzi A; Liang C
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells.
    Muratori C; Cavallin LE; Krätzel K; Tinari A; De Milito A; Fais S; D'Aloja P; Federico M; Vullo V; Fomina A; Mesri EA; Superti F; Baur AS
    Cell Host Microbe; 2009 Sep; 6(3):218-30. PubMed ID: 19748464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Contribution of Extracellular Nef to HIV-Induced Pathogenesis.
    Olivetta E; Arenaccio C; Manfredi F; Anticoli S; Federico M
    Curr Drug Targets; 2016; 17(1):46-53. PubMed ID: 26424397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.
    Lenassi M; Cagney G; Liao M; Vaupotic T; Bartholomeeusen K; Cheng Y; Krogan NJ; Plemenitas A; Peterlin BM
    Traffic; 2010 Jan; 11(1):110-22. PubMed ID: 19912576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuro-HIV-New insights into pathogenesis and emerging therapeutic targets.
    Sviridov D; Bukrinsky M
    FASEB J; 2023 Dec; 37(12):e23301. PubMed ID: 37942865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifunctional Roles of the N-Terminal Region of HIV-1
    Ananth S; Morath K; Trautz B; Tibroni N; Shytaj IL; Obermaier B; Stolp B; Lusic M; Fackler OT
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.